Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Skåne Dairy in connection with its sale of shares in ProViva AB to Danone and formation of a joint venture
Mandate

Vinge advises Skåne Dairy in connection with its sale of shares in ProViva AB to Danone and formation of a joint venture

September 29, 2010

Vinge has advised Skåne Dairy in connection with the sale of 51 per cent of the shares in ProViva AB to Danone. Pursuant to the terms of the agreement, the parties’ joint ownership of the company will commence at the end of 2010 and Danone will thereafter increase its stake in ProViva over the course of an 11-year period culminating in the company ultimately becoming wholly-owned by Danone. ProViva is a health drink containing a bacteria called Lactobacillus plantarum 299v, which was developed by Skåne Dairy in co-operation with Probi. The Danone Group is one of the world’s leading providers of fresh dairy products and its products include the Swedish registered brands Actimel, Activia and Danio.

Vinge’s team consisted of partner Björn Mullaart together with associates Kristian Ford, Anna Jonsson and Markus Larsson. Partner Ingela Malmborg and associate Therese Lindholm provided employment law advice and Ingela Malmborg together with associate Mathias Lindquist provided environmental law and permit compliance advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025